0.25% Acetic Acid Irrigation USP | Acetic Acid

07:59 EDT 1st July 2015 | BioPortfolio
Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

Package Insert

PIC™ (Plastic Irrigation Containers)

Urologic Irrigating Fluid for Patients Requiring ProlongedIndwelling Urethral Catheterization.Not for Transurethral Surgical Procedures.Not for Injection.

Each 100 mL contains:Glacial Acetic Acid USP 0.25 gWater for Injection USP qs

pH: 3.1 (2.8–3.4)Calculated Osmolarity: 42 mOsmol/liter

The formula of the active ingredient is:

0.25% Acetic Acid Irrigation USP is a prediluted, sterile, nonpyrogenic aqueous solution suitable for urologic irrigation. It contains no preservatives or added buffers. The solution is hypotonic.

The plastic container is a copolymer of ethylene and propylene formulated and developed for parenteral drugs. The copolymer contains no plasticizers and exhibits virtually no leachability. The plastic container is also virtually impermeable to vapor transmission and therefore, requires no overwrap to maintain the proper drug concentration. The safety of the plastic container has been confirmed by biological evaluation procedures. The material passes Class Vl testing as specified in the U.S. Pharmacopeia for Biological Tests — Plastic Containers. These tests have shown that the container is nontoxic and biologically inert.

The PIC Container is PVC-free and DEHP-free.

Ingredient Molecular Formula Molecular Weight
Glacial Acetic Acid USP CH3COOH 60.05

Irrigation of the urinary bladder with acetic acid solution in a concentration of 0.25% has been shown to exert an antimicrobial action against a variety of microorganisms (especially ammonia-forming bacteria) that frequently gain access to the urinary bladder in patients who require prolonged indwelling urethral catheterization. Its antimicrobial action is dependent on administration via the indwelling catheter at a sufficient rate (continuous or intermittent) to maintain an effluent pH of 5.0 or lower. Maintenance of low pH of bladder urine also helps reduce formation of calcium encrustations in the indwelling catheter.

0.25% Acetic Acid Irrigation USP is indicated as a constant or intermittent bladder rinse to help prevent the growth and proliferation of susceptible urinary pathogens (especially ammonia-forming bacteria) in the management of patients who require prolonged placement of an indwelling urethral catheter. It also may be used for periodic irrigation of an indwelling catheter to help maintain patency by reducing the formation of calcium encrustations.

0.25% Acetic Acid Irrigation USP is not for injection.

This solution is contraindicated for irrigation during transurethral surgical procedures.

FOR UROLOGIC IRRIGATION ONLY. NOT FOR INJECTION.

Use of this solution in patients with mucosal lesions of the urinary bladder may be harmful due to irritation of the lesion. Absorption via open lesions of the bladder mucosa may result in systemic acidosis.

Do not warm above 150°F (66°C).

After opening container, the contents should be used promptly in order to minimize the possibility of bacterial growth or pyrogen formation.

Discard unused portion of irrigating solution since it contains no preservative.

Use aseptic technique when preparing and administering sterile irrigation solutions.

Use only if solution is clear and container and seal are intact.

If pain or hematuria should occur during irrigation, it should be discontinued and the patient reevaluated.

When used for irrigation via appropriate irrigation equipment, the administration set should be attached promptly. Unused portions should be discarded and a fresh container of appropriate size used for the start up of each cycle or repeat procedure. For repeated irrigations of urethral catheters, a separate container should be used for each patient.

Studies with 0.25% Acetic Acid Irrigation USP have not been performed to evaluate carcinogenic potential, mutagenic potential, or effects on fertility.

Animal reproduction studies have not been conducted with 0.25% Acetic Acid Irrigation USP. It is also not known whether 0.25% Acetic Acid Irrigation USP can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. 0.25% Acetic Acid Irrigation USP should be given to a pregnant woman only if clearly needed.

Caution should be exercised when 0.25% Acetic Acid Irrigation USP is administered to a nursing woman.

Safety and effectiveness in pediatric patients have not been established.

Clinical studies of 0.25% Acetic Acid Irrigation USP have not been performed to determine whether patients over 65 years of age respond differently from younger subjects. Although systemic absorption of the product is unlikely, greater sensitivity of some older individuals cannot be ruled out.

Systemic acidosis, pain, and hematuria have been reported in patients receiving urinary bladder irrigation with 0.25% acetic acid solution.

If an adverse reaction does occur, discontinue administration of the irrigant, evaluate the patient, institute appropriate therapeutic countermeasures, and save the remainder of the fluid for examination, if deemed necessary.

Systemic absorption is unlikely unless there are open lesions of the bladder mucosa that have gone undetected. In such event, discontinue the irrigation, evaluate the patient for possible systemic acidosis, intravascular hemolysis, and circulatory overload and institute appropriate countermeasures as indicated. See WARNINGS, PRECAUTIONS, and ADVERSE REACTIONS .

As required for urologic irrigation.

0.25% Acetic Acid Irrigation USP may be administered by gravity drip via an administration set connected to an indwelling urethral catheter designed for continuous or intermittent two-way flow.

For continuous or intermittent irrigation, the rate of administration will correspond roughly to the rate of urine flow and should be adjusted to maintain a urinary effluent pH of 4.5 to 5.0.

Nitrazine or other pH paper may be used to monitor pH, preferably at least four times daily. Drip rate should be adjusted as necessary to maintain desired pH; increasing flow rate reduces pH value and vice versa. With continuous or intermittent irrigation, each patient will require a volume of approximately 500 to 1500 mL per 24 hours.

Some additives may be incompatible. Consult with pharmacist. When introducing additives, use aseptic techniques. Mix thoroughly. Do not store.

This drug product should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.

0.25% Acetic Acid Irrigation USP is supplied sterile and nonpyrogenic in 1000 mL and 500 mL PIC™ (Plastic Irrigation Containers) packaged 16 per case.

NDC Cat. No. Size
0.25% Acetic Acid Irrigation USP
0264-2304-00 R6600-01 1000 mL
0264-2304-10 R6601-01 500 mL

Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. Protect from freezing. It is recommended that the product be stored at room temperature (25°C); however, brief exposure up to 40°C does not adversely affect the product.

Do not warm above 150°F (66°C).

Rx only

Revised: March 2009

PIC is a trademark of B. Braun Medical Inc.

Not for injection.

Aseptic technique is required.

Use only if solution is clear and container and seal are intact.

Single dose container. Discard unused portion.

IMAGE acetic-acid-01.jpgIMAGE acetic-acid-02.jpg

B. Braun Medical Inc. Irvine, CA 92614-5895 USAMade in USA

Y36-002-694

0.25% Acetic AcidIrrigation USP

REF R6600-01NDC 0264-2304-00 1000 mL

Each 100 mL contains:Glacial Acetic Acid USP 0.25 gWater for Injection USP qs

pH: 3.1 (2.8–3.4)Calc. Osmolarity: 42 mOsmol/liter,hypotonic

Not for Injection or TransurethralSurgery: Use only if solution is clear andcontainer and seal are intact.

Sterile, nonpyrogenic.Single dose container.

Warning: Do not warm above 150°F (66°C).

Recommended Storage:Room temperature (25°C).Avoid excessive heat.Protect from freezing.See Package Insert.

Rx only

PVC-free and DEHP-free

B. Braun Medical Inc. Irvine, CA 92614-5895 USAMade in USA

Lot.Exp.

Y37-002-327

IMAGE acetic-acid-03.jpg

0.25% Acetic AcidIrrigation USP

REF R6601-01NDC 0264-2304-10 500 mL

Each 100 mL contains:Glacial Acetic Acid USP 0.25 gWater for Injection USP qs

pH: 3.1 (2.8–3.4)Calc. Osmolarity: 42 mOsmol/liter,hypotonic

Not for Injection or TransurethralSurgery: Use only if solution is clear andcontainer and seal are intact.

Sterile, nonpyrogenic.Single dose container.

Warning: Do not warm above 150°F (66°C).

Recommended Storage:Room temperature (25°C).Avoid excessive heat.Protect from freezing.See Package Insert.

Rx only

PVC-free and DEHP-free

B. Braun Medical Inc. Irvine, CA 92614-5895 USAMade in USA

Lot.Exp.

Y37-002-328

IMAGE acetic-acid-04.jpg

Manufacturer

B. Braun Medical Inc.

Active Ingredients

Source

Drugs and Medications [82 Associated Drugs and Medications listed on BioPortfolio]

Acetic acid [Hi-Tech Pharmacal Co., Inc.]

Acetic Acid Otic Solution, USP

Acetic acid [Qualitest Pharmaceuticals]

ACETIC ACID OTIC SOLUTION, USP

Borofair [Major Pharmaceuticals]

Acetic Acid in AqueousAluminum Acetate

Acetic acid [Bausch & Lomb Incorporated]

Acetic Acid 2% in AqueousAluminum Acetate Otic Solution

Hydrocortisone and acetic acid [Hi-Tech Pharmacal Co., Inc.]

Hydrocortisone and Acetic Acid Otic Solution, USP

Clinical Trials [1371 Associated Clinical Trials listed on BioPortfolio]

Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery

RATIONALE: Drugs used in chemotherapy such as gossypol acetic acid, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing....

Paclitaxel, Carboplatin, and Dimethylxanthenone Acetic Acid in Treating Patients With Extensive-Stage Small Cell Lung Cancer

RATIONALE: Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from di...

Lenalidomide and AT-101 in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia

This phase I/II trial studies the side effects and best dose of lenalidomide when given together with R-(-)-gossypol acetic acid and to see how well they work in treating patients with rel...

Measurement of Digital Colposcopy for Fluorescence Spectroscopy of TNC Using a Second Device

The overall objective of this study is to identify potential improvements for a noninvasive method of diagnosing dysplasia and neoplasia in the cervix using Multi-spectral Digital Colposco...

Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma

To evaluate the efficacy of Seocalcitol in prolonging time to relapse following intended curative resection or percutaneous ablative treatment, i.e. percutaneous ethanol injection(s), perc...

PubMed Articles [7111 Associated PubMed Articles listed on BioPortfolio]

Acetic acid enhances endurance capacity of exercise-trained mice by increasing skeletal muscle oxidative properties.

Acetic acid has been shown to promote glycogen replenishment in skeletal muscle during exercise training. In this study, we investigated the effects of acetic acid on endurance capacity and muscle oxi...

Acetic Acid Induces pH-Independent Cellular Energy Depletion in Salmonella enterica.

Abstract Weak organic acids are widely used as preservatives and disinfectants in the food industry. Despite their widespread use, the antimicrobial mode of action of organic acids is still not fully ...

Biotransformations of 2-hydroxy-2-(ethoxyphenylphosphinyl)acetic acid and the determination of the absolute configuration of all isomers.

2-Hydroxy-2-(ethoxyphenylphosphinyl)acetic acid, a new type of organophosphorus compound possessing two stereogenic centers, was investigated. Racemic 2-butyryloxy-2-(ethoxyphenylphosphinyl)acetic aci...

Acetic acid induces cell death: An in vitro study using normal rat gastric mucosal cell line and rat and human gastric cancer and mesothelioma cell lines.

We recently reported that topical application of acetic acid promptly caused tumor necrosis in a mouse model of gastric cancer. The aim of the present study was to examine whether acetic acid can dire...

Packaging performance of organic acid incorporated chitosan films on dried anchovy (Stolephorus indicus).

Antimicrobial chitosan films were prepared with acetic acid and propionic acid with glycerol as plasticizer and its efficiency was compared with polyester-polyethylene laminate (PEST/LDPE). The tensil...


Advertisement
 

Relevant Topics

Drug Discovery
Latest News Clinical Trials Research Drugs Reports Corporate
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Biological Therapy
Latest News Clinical Trials Research Drugs Reports Corporate
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Advertisement
 

Drugs and Medication Quicklinks


Searches Linking to this Drug Record